We found that ALKBH1, TRMT6, TRMT10C, YTHDF1, and YTHDF2 were significantly overexpressed in high-grade gliomas and the expression of TRMT6 and YTHDF2 was higher in IDH wild-type patients. Here, TRMT6 is linked to central nervous system cancer.